Skip to main content
. 2020 Aug 25;8(3):473. doi: 10.3390/vaccines8030473

Table 2.

Prevalence of IgG antibodies reacting to HPV-16 L1 capsid protein detected in sera from SA and VI groups.

Groups Number of Sera Median Age ± SD Number of Positive Samples/Total of Samples (%)
SA 80 35 ± 4 30 (37.5)
VI 80 31 ± 5 24 (30)